Literature DB >> 8833751

Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus.

H Ishimaru1, K Ishikawa, Y Ohe, A Takahashi, Y Maruyama.   

Abstract

The distribution patterns of cystatin C and apolipoprotein E (apo E) were studied immunocytochemically in the gerbil hippocampus before and after 5 min ischemia. In the controls, cystatin C was distributed mainly in astrocytes. In addition, a large number of dots positive for cystatin C were observed around the outlines of neuronal perikarya in the CA1 subfields. One day after ischemia, cystatin C-positive stainings outlining neuronal cell bodies disappeared. On the fourth day, intense stainings for cystatin C appeared in atrophied pyramidal neurons and these stainings in neurons disappeared by the 14th day. A remarkable increase in the number of cystatin C-positive astrocytes occurred on the fourth day and thereafter these spread over the whole of the CA1 subfield. Apo E was also distributed in astrocytes in the control specimens. From the fourth day, extra- and/or intracellular distribution of apo E-immunoreactivities was noted in the stratum pyramidale. Apo E-positive astrocytes disappeared transiently on the fourth day and then reappeared and increased remarkably by the 14th day. These findings indicate that cystatin C and apo E are involved in the degeneration process of brain neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833751     DOI: 10.1016/0006-8993(95)01232-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

Authors:  I Tesseur; J Van Dorpe; K Spittaels; C Van den Haute; D Moechars; F Van Leuven
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack.

Authors:  Xiaoyu Dong; Jianfei Nao
Journal:  Neurotox Res       Date:  2019-07-02       Impact factor: 3.911

3.  Elevation of cystatin C in susceptible neurons in Alzheimer's disease.

Authors:  A Deng; M C Irizarry; R M Nitsch; J H Growdon; G W Rebeck
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke.

Authors:  Bo Yang; Jiangtao Zhu; Zhigang Miao; Beiqun Zhou; Wei Ge; Heqing Zhao; Xingshun Xu
Journal:  Neurotox Res       Date:  2015-02-20       Impact factor: 3.911

Review 5.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

Review 6.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

7.  Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy.

Authors:  Gurjinder Kaur; Panaiyur Mohan; Monika Pawlik; Steven DeRosa; Jay Fajiculay; Shaoli Che; Anders Grubb; Stephen D Ginsberg; Ralph A Nixon; Efrat Levy
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

8.  Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.

Authors:  Eillen J Rodriguez-Franco; Yisel M Cantres-Rosario; Marines Plaud-Valentin; Rafael Romeu; Yolanda Rodríguez; Richard Skolasky; Viviana Meléndez; Carmen L Cadilla; Loyda M Melendez
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  Cystatin C in Alzheimer's disease.

Authors:  Gurjinder Kaur; Efrat Levy
Journal:  Front Mol Neurosci       Date:  2012-07-06       Impact factor: 5.639

10.  Cystatins in immune system.

Authors:  Spela Magister; Janko Kos
Journal:  J Cancer       Date:  2012-12-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.